Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?

Prostate cancer (PCa) is the most common cancer in men. Androgen receptor axis plays a crucial role in the carcinogenesis of PCa. The mainstay treatment of prostate cancer is blockage of androgen receptor axis but in a vast majority of patient resistance to androgen deprivation therapy is inevitable...

Descripción completa

Detalles Bibliográficos
Autores principales: Yekedüz, Emre, Utkan, Güngör, Kanesvaran, Ravindran, Ürün, Yüksel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053696/
https://www.ncbi.nlm.nih.gov/pubmed/33912507
http://dx.doi.org/10.1016/j.prnil.2020.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053696/
https://www.ncbi.nlm.nih.gov/pubmed/33912507
http://dx.doi.org/10.1016/j.prnil.2020.03.002

Ejemplares similares